USFDA’s nod for Kerala’s local herb Manathakkali for Liver Cancer Treatment

The US agency has given the compound an ‘orphan drug’ designation

1034
USFDA
Picture: Pixabay

Last Updated on November 8, 2021 by The Health Master

USFDA’s nod for Kerala’s local herb Manathakkali

THIRUVANANTHAPURAM: ‘Manathakkali’ (Black nightshade or Solanum nigrum), a berry-bearing shrub found in the backyard, is traditionally known for its medicinal value.

Now the United States Food and Drug Administration (FDA) has noticed the potential of a compound isolated from the plant to treat liver cancer, thanks to the findings of a team of scientists at Rajiv Gandhi Centre for Biotechnology (RGCB).

The US agency has given the compound an ‘orphan drug’ designation, which helps in the development and evaluation of new treatments for rare diseases.

It will also help fast-track the drug’s approval. RGCB senior scientist Dr Ruby John Anto, who along with her student Dr Lekshmi R Nath isolated the drug molecule — Uttroside-B — from the leaves of Manathakkali plant, said:

“There is only one USFDA-approved drug available for liver cancer treatment at present. The compound we developed has found to be more effective than the one available.

Toxicity evaluation in human volunteers has shown that the compound is also effective in treating fatty liver.”

The technology they patented has been bought by US pharma company QBioMed. The technology transfer was done through Oklahoma Medical Research Foundation.

According to RGCB Director Dr Chandrabhas Narayana, the research will prove to be a major breakthrough in treatment of liver diseases, including liver cancer. 

Manathakkali: RGCB director says findings path-breaking

“The findings are pathbreaking, given that the liver which primarily detoxifies food while aiding digestion is found to be increasingly susceptible to cancer in modern times.

The malignant disease of the liver is estimated to kill no less than 8 lakh people annually even as 9 lakh new cases are reported every year,” said the RGCB director.

Dr Ruby and her team is currently studying the mechanism of action of the compound and evaluating its efficacy against fatty liver disease, non-alcoholic SteatoHepatitis and liver cancer caused by food toxins.

This is done in collaboration with Dr L Ravishankar (CSIR-NIST, Thiruvananthapuram), who has developed a novel method to isolate the compound from solanum nigrum leaves.

USFDA nod for Cortrophin Gel to treat Autoimmune Disorders

Allergan gets USFDA nod for eye drop to treat blurry vision

Novartis gets USFDA approval for drug to treat Chronic Leukemia

Aurobindo Pharma gets USFDA nod for cancer treatment drug

USFDA approves drug for severe Itching in kidney disease patients

Zydus Cadila gets USFDA nod for Tofacitinib ER Tablets

Gujarat FDCA issues huge number of Product Permissions

Excipients industry may face similar fate like Bulk drugs: Pharmexcil

Novavax, Serum Institute seek approval from WHO for Covid-19 vaccine

India: Gland Pharma heading towards Complex Injectables segments

Artificial Intelligence will be used to discover New Drugs: Google

UK becomes first country to approve anti-Covid pill

Govt Job for Drug Inspector, Assistant Drug Inspector

Lupin sets up Guinness World Records

Duties of Retail Chemists / Medical Store / Pharmacy

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner